1. Prostate cancer is the most common cancer among American men, with over 234,000 new cases diagnosed each year.
2. Prostate cancer often does not cause symptoms in its early stages. When symptoms do occur, the cancer has usually spread beyond the prostate. Regular screening is recommended for men starting at age 40.
3. Risk factors for prostate cancer include increasing age, family history of the disease, and race. African American men face higher risks and are more likely to die from prostate cancer.
Foe whatever the physical virtues of maleness, longeivity is not among them. Every year, almost 1,00,000 men are dying prematurely compared to 66,000 women. Women live longer than men
Prostate cancer may be the third most typical cancer amongst men within India, and also the second most often diagnosed most cancers among males worldwide, along with 70% instances occurring within developed nations. What models this most cancer apart (other compared to its commonality), is exactly how brilliantly treatable it's. The 5-year success rate for many men along with non-metastatic Prostate Cancer is almost 100%.
Understanding how intermittent fasting may not only help weight loss but have multiple other health benefits including life prolongation, preventing cancer and dementia
About 50% of all men by 50years will have prostate cancer cells at the dormant stage in their prostate gland so the question now is why are there great geographical prostate cancer variations? It is also believed men of Africa descent have high androgen level than white men and is the fuel for prostate cancer. According to a publication by the Ghana news Agency, Ghana has exceeded the global prostate limits as the country records 200 cases out of every 100,000 men as against 170 world-wide, a survey by the Korle -Bu Teaching Hospital revealed(GNA - August, 07, 2007). This study aims to look at the impact of alternative medicine on Ghanaian men of African descent diagnosed with prostate cancer. This research study is in two forms, firstly an observational study will be used to assess Ghanaian men diagnosed with Prostate cancer and the use of traditional medicinal plant call croton membranaceus to ascertain its anti cancer efficacy. Croton membranaceus root extract marketed as URO 500 at Center For Plant Medicine Research in Ghana (Mampong , Akuapem) 10mg per capsule will be given to about 30 patient diagnosed with Prostate Cancer at the experimental site , De Menâs Clinic & Prostate Research Lab in Dodowa, Akoto House for an observational study to be conducted and cohort for this important research will report after three month of treatment after which their PSA will be assess again as the PSA is the best marker in terms of the diseases monitoring or progressing.
Secondly, an extensive research using online search engines to conduct a literature review, summarizing the body of evidence on impact of alternative medicine and prostate cancer use in men of African descent to date will be use for this important second phase of the study.
Results will be analyzed using the PSA at the stage at diagnosis and after treatment with the croton membranous. The International Prostate Symptoms score (IPSS) and the international Index of Erectile Function (IIEF) questionnaire will also be assessing before and after. Abdominopelvic Scan using Sonoscape A6 with full bladder to enable acoustic widow to assess prostate Volume before and after will also be access.
Cancer is a disease caused when cells divide uncontrollably and spread into surrounding tissues. Cancer is caused by changes to DNA. Most cancer-causing DNA changes occur in sections of DNA called genes. These changes are also called genetic changes.
Foe whatever the physical virtues of maleness, longeivity is not among them. Every year, almost 1,00,000 men are dying prematurely compared to 66,000 women. Women live longer than men
Prostate cancer may be the third most typical cancer amongst men within India, and also the second most often diagnosed most cancers among males worldwide, along with 70% instances occurring within developed nations. What models this most cancer apart (other compared to its commonality), is exactly how brilliantly treatable it's. The 5-year success rate for many men along with non-metastatic Prostate Cancer is almost 100%.
Understanding how intermittent fasting may not only help weight loss but have multiple other health benefits including life prolongation, preventing cancer and dementia
About 50% of all men by 50years will have prostate cancer cells at the dormant stage in their prostate gland so the question now is why are there great geographical prostate cancer variations? It is also believed men of Africa descent have high androgen level than white men and is the fuel for prostate cancer. According to a publication by the Ghana news Agency, Ghana has exceeded the global prostate limits as the country records 200 cases out of every 100,000 men as against 170 world-wide, a survey by the Korle -Bu Teaching Hospital revealed(GNA - August, 07, 2007). This study aims to look at the impact of alternative medicine on Ghanaian men of African descent diagnosed with prostate cancer. This research study is in two forms, firstly an observational study will be used to assess Ghanaian men diagnosed with Prostate cancer and the use of traditional medicinal plant call croton membranaceus to ascertain its anti cancer efficacy. Croton membranaceus root extract marketed as URO 500 at Center For Plant Medicine Research in Ghana (Mampong , Akuapem) 10mg per capsule will be given to about 30 patient diagnosed with Prostate Cancer at the experimental site , De Menâs Clinic & Prostate Research Lab in Dodowa, Akoto House for an observational study to be conducted and cohort for this important research will report after three month of treatment after which their PSA will be assess again as the PSA is the best marker in terms of the diseases monitoring or progressing.
Secondly, an extensive research using online search engines to conduct a literature review, summarizing the body of evidence on impact of alternative medicine and prostate cancer use in men of African descent to date will be use for this important second phase of the study.
Results will be analyzed using the PSA at the stage at diagnosis and after treatment with the croton membranous. The International Prostate Symptoms score (IPSS) and the international Index of Erectile Function (IIEF) questionnaire will also be assessing before and after. Abdominopelvic Scan using Sonoscape A6 with full bladder to enable acoustic widow to assess prostate Volume before and after will also be access.
Cancer is a disease caused when cells divide uncontrollably and spread into surrounding tissues. Cancer is caused by changes to DNA. Most cancer-causing DNA changes occur in sections of DNA called genes. These changes are also called genetic changes.
CSS style blocks are often referred to as rules. These rules can be set into an HTML page or in an external file that controls the different pages of your website.
Una serie di slides che presentano i punti essenziali della teoria di Zecharia Sitchin, disposti in modo da formare una cronologia della origine delle civiltĂ mediorientali, dall' arrivo degli Anunnaki al bombardamento del Sinai e consecutiva nascita di Babilonia.
Having studied the basic foundational truths of the Christian church, it is now time for us to examine more closely the church itself. Three basic questions need to be answered in relation to the church, namely What is the Church? How do we identify the church when we see it? & How is the church supposed to engage the world?
Cancer Awareness - Kaplan University Dept. of Public Healthsmtibor
Â
Cancer awareness, including general definitions, detection, prevention, treatment, and risk factors. Emphasis on skin and prostate cancers and at-risk populations.
An introduction to week 1 of a free online course on enhancing prostate cancer care, delivered by Sheffield Hallam University in the UK (Oct-Nov 2014). Week 1 focuses on diagnosis.
This November, the Cancer Association of South Africa (CANSA) calls on men to be responsible for their health and to take advantage of cancer screening available at CANSA Care Centres. The five leading cancers affecting men * according to the 2016 National Cancer Registry (NCR) are prostate, colorectal, lung, non-Hodgkinâs lymphoma and bladder cancer. #CANSAscreening #MensHealth
https://cansa.org.za/mens-health/
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowmanâs Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Â
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? â The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
Â
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years â 64.8%, 20 years â 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP â more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0âN12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0âN12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Â
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
Â
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Factory Supply Best Quality Pmk Oil CAS 28578â16â7 PMK Powder in Stockrebeccabio
Â
Factory Supply Best Quality Pmk Oil CAS 28578â16â7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Prix Galien International 2024 Forum ProgramLevi Shapiro
Â
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMENâS HEALTH: FERTILITY PRESERVATION
- WHATâS NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
Â
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Departmentâs official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Â
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
5. Cancer Incidence * 87% of lung and bronchus are related to smoking Source: American Cancer Society. Jemal A, et al. Cancer Statistics, 2004. CA Cancer J Clin. 2005;55:10-30 50% 17% 8% 6% 3% 2% 2% 1% 1% 0% 10% 20% 30% 40% 50% All Sites Prostate Lung & Bronchus Colon & Rectal Bladder Lymphoma Melanoma Oral Kidney Risk A non-smoking man is more likely to get prostate cancer than lung, bronchus, colon, rectal, bladder, lymphoma, melanoma, oral, and kidney cancers combined .
6. Age-Specific Probability of Diagnosis Source: 2000-2002 SEER 13 Registries Age-Specific Probability of Diagnosis Age Prostate Breast Colon Lung & Bronchus Leukemia & Lymphoma Pancreas 0% 2% 4% 6% 8% 10% 12% 14% 16% 18% 25 30 35 40 45 50 55 60 65 70 75 80 85 90
7. Assumes 2002 age-specific incidence rates. Source: SEER 13 Registries Incidence and Mortality (2004 Submission) 300,000 350,000 400,000 460,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 2000 2005 2010 2015 2020 2025 2030 2035 2040 2045 2050 Prostate Breast Lung & Bronchus Colon Number of New Cases
8. Historical & Projected Cancer Deaths Note: Projections Assume 1999 Age Specific Mortality Rates. 10,000 30,000 50,000 70,000 90,000 110,000 130,000 1975 1980 1985 1990 1995 2000 2005 2010 2015 2020 2025 2030 2035 2040 2045 2050 Prostate 52,000 deaths in 2020 10,000 30,000 50,000 70,000 90,000 110,000 130,000 1975 1980 1985 1990 1995 2000 2005 2010 2015 2020 2025 2030 2035 2040 2045 2050 Deaths Breast 40,000 deaths in 2010 52,000 deaths in 2020 80,000 deaths in 2030
10. 30% of Men & Women Believe Women Can Get Prostate Cancer 30%
11. 30% of Men & Women Believe Women Can Get Prostate Cancer 30% WOMEN DONâT HAVE PROSTATES
12. 2006 Estimated U.S. Cancer Cases Prostate 19% 234,460 cases Breast 18% 212,920 cases * Excludes basal and squamous cell skin cancers and in situ carcinoma except bladder. Percentages may not total 100% due to rounding. Source: American Cancer Society. Cancer Facts & Figures 2006 . Atlanta: American Cancer Society; 2006. Uterine 3% Pancreas 3% Ovary 2% Kidney 3% Oral Cavity 3% Thyroid 3% Non-Hodgkin Lymphoma 5% Leukemia 3% Melanoma 5% Bladder 5% Colon & Rectum 13% Lung & Bronchus 15%
13. = 1.33 more likely men will develop prostate cancer 1 6 1 8 women will develop breast cancer
14. Concerned About Prostate Cancer and Taking Action Concerned About Prostate Cancer Never Discuss Family History or Personal Risk with Doctor
15. Women as Influences More Likely to Talk to Doctor if Urged by Women in Their Lives MEN Believe They Can Influence Men to See Doctor WOMEN
16. Symptoms and Early Stage Prostate Cancer Men believe that there are symptoms associated with early stage prostate cancer 30%
17. EARLY STAGE PROSTATE CANCER TYPICALLY DOESNâT HAVE SYMPTOMS Men believe that there are symptoms associated with early stage prostate cancer Symptoms and Early Stage Prostate Cancer 30%
18.
19.
20. Family history Prostate cancer seems to run in some families, which suggests that in some cases there may be an inherited or genetic factor. Having a father or brother with prostate cancer more than doubles a man's risk of developing this disease. (The risk is higher for men with an affected brother than for those with an affected father.) The risk is much higher for men with several affected relatives, particularly if their relatives were young at the time the cancer was found
21. Race/ethnicity Prostate cancer occurs more often in African-American men than in men of other races. African-American men are also more likely to be diagnosed at an advanced stage, and are more than twice as likely to die of prostate cancer as white men. Prostate cancer occurs less often in Asian-American and Hispanic/Latino men than in non-Hispanic whites. The reasons for these racial and ethnic differences are not clear.
22. Nationality Prostate cancer is most common in North America, northwestern Europe, Australia, and on Caribbean islands. It is less common in Asia, Africa, Central America, and South America. The reasons for this are not clear. More intensive screening in some developed countries likely accounts for at least part of this difference, but other factors are likely to be important as well. For example, lifestyle differences (diet, etc.) may be important: men of Asian descent living in the United States have a lower risk of prostate cancer than white Americans, but their risk is higher than that of men of similar backgrounds living in Asia.
23. Diet The exact role of diet in prostate cancer is not clear, although several different factors have been studied. Men who eat a lot of red meat or high-fat dairy products appear to have a slightly higher chance of getting prostate cancer. These men also tend to eat fewer fruits and vegetables. Doctors are not sure which of these factors is responsible for raising the risk. Some studies have suggested that men who consume a lot of calcium (through food or supplements) may have a higher risk of developing advanced prostate cancer. Most studies have not found such a link with the levels of calcium found in the average diet, and it's important to note that calcium is known to have other important health benefits.
24. Obesity Most studies have not found that being obese (having a high amount of extra body fat) is linked with a higher risk of getting prostate cancer. Some studies have found that obese men have a lower risk of getting a low-grade (less dangerous) form of the disease, but a higher risk of getting more aggressive prostate cancer. The reasons for this are not clear. Studies have also found that obese men may be at greater risk for having more advanced prostate cancer and of dying from prostate cancer, but this was not seen in other studies.
25. Exercise Exercise has not been shown to reduce prostate cancer risk in most studies. But some studies have found that high levels of physical activity, particularly in older men, may lower the risk of advanced prostate cancer. More research in this area is needed
26. Inflammation of the prostate Some studies have suggested that prostatitis (inflammation of the prostate gland) may be linked to an increased risk of prostate cancer, but other studies have not found such a link. Inflammation is often seen in samples of prostate tissue that also contain cancer. While the link between the two is not yet clear, this is an active area of research.
27. Infection Researchers have also looked to see if sexually transmitted infections (like gonorrhea or chlamydia) might increase the risk of prostate cancer, possibly by leading to inflammation of the prostate. So far, studies have not agreed, and no firm conclusions have been reached .
28. Vasectomy Some earlier studies had suggested that men who had a vasectomy (minor surgery to make men infertile) -- especially those younger than 35 at the time of the procedure -- may have a slightly increased risk for prostate cancer. But most recent studies have not found any increased risk among men who have had this operation. Fear of an increased risk of prostate cancer should not be a reason to avoid a vasectomy
29. Kataja VV, Bergh J. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer. Ann Oncol . 2005;16 Suppl 1:i34-6. Chang SS, Benson MC, Campbell SC, Crook J, Dreicer R, Evans CP, Hall MC, Higano C, Kelly WK, Sartor O, Smith JA Jr; Society of Urologic Oncology, Shaumberg, Illinois. Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma. Cancer . 2005 Jan 1;103(1):11-21.